Graphene Oxide Scaﬀold Stimulates Diﬀerentiation and Proangiogenic Activities of Myogenic Progenitor Cells by Wierzbicki, Mateusz et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Graphene Oxide Scaold Stimulates Dierentiation and Proangiogenic Activities of
Myogenic Progenitor Cells
Wierzbicki, Mateusz; Hotowy, Anna; Kutwin, Marta; Jaworski, Slawomir; Baaban, Jamina;
Sosnowska, Malwina Ewa; Wójcik ,  Barbara Wójcik ; Wedzinska ,  Aleksandra ; Chwalibog,
André; Sawosz, Ewa
Published in:
International Journal of Molecular Sciences
DOI:
10.3390/ijms21114173
Publication date:
2020
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Wierzbicki, M., Hotowy, A., Kutwin, M., Jaworski, S., Baaban, J., Sosnowska, M. E., ... Sawosz, E. (2020).
Graphene Oxide Scaold Stimulates Dierentiation and Proangiogenic Activities of Myogenic Progenitor Cells.
International Journal of Molecular Sciences , 21, [4173]. https://doi.org/10.3390/ijms21114173
Download date: 10. Sep. 2020
 International Journal of 
Molecular Sciences
Article
Graphene Oxide Scaffold Stimulates Differentiation
and Proangiogenic Activities of Myogenic
Progenitor Cells
Mateusz Wierzbicki 1,*, Anna Hotowy 1 , Marta Kutwin 1, Sławomir Jaworski 1,
Jas´mina Bałaban 1, Malwina Sosnowska 1, Barbara Wójcik 1, Aleksandra We˛dzin´ska 1,
André Chwalibog 2 and Ewa Sawosz 1
1 Department of Nanobiotechnology and Experimental Ecology, Institute of Biology, Warsaw University of
Life Sciences, Ciszewskiego 8, 02-786 Warsaw, Poland; anna_hotowy@sggw.edu.pl (A.H.);
marta_kutwin@sggw.edu.pl (M.K.); slawomir_jaworski@sggw.edu.pl (S.J.);
jasmina_balaban@sggw.edu.pl (J.B.); malwina_sosnowska@sggw.edu.pl (M.S.);
barbara_wojcik@sggw.edu.pl (B.W.); a.wedzinska1@gmail.com (A.W.);
ewa_sawosz_chwalibog@sggw.edu.pl (E.S.)
2 Department of Veterinary and Animal Sciences, University of Copenhagen, Groennegaardsvej 3,
1870 Frederiksberg, Denmark; ach@sund.ku.dk
* Correspondence: mateusz_wierzbicki@sggw.edu.pl
Received: 10 May 2020; Accepted: 9 June 2020; Published: 11 June 2020


Abstract: The physiological process of muscle regeneration is quite limited due to low satellite
cell quantity and also the inability to regenerate and reconstruct niche tissue. The purpose of the
study was to examine whether a graphene oxide scaffold is able to stimulate myogenic progenitor
cell proliferation and the endocrine functions of differentiating cells, and therefore, their active
participation in the construction of muscle tissue. Studies were carried out using mesenchymal cells
taken from 6-day-old chicken embryos and human umbilical vein endothelial cells (HUVEC) were
used to assess angiogenesis. The graphene scaffold was readily colonized by myogenic progenitor
cells and the cells dissected from heart, brain, eye, and blood vessels did not avoid the scaffold.
The scaffold strongly induced myogenic progenitor cell signaling pathways and simultaneously
activated proangiogenic signaling pathways via exocrine vascular endothelial growth factor (VEGF)
secretion. The present study revealed that the graphene oxide (GO) scaffold initiates the processes of
muscle cell differentiation due to mechanical interaction with myogenic progenitor cell.
Keywords: angiogenesis; myogenic progenitor cells; graphene oxide
1. Introduction
Degradation, degeneration, and surgical removal are among the most common causes of muscle
loss. These processes are largely irreversible. Despite the ability of muscle cells to regenerate,
the physiological process of regeneration is quite limited. This is because there exist a limited
number of satellite cells, and also a result of the inability of a muscle to regenerate and reconstruct its
niche. The niche, which is the immediate environment of stem cells, well cell availability and growth
factors mutually influence each other and are required for the regeneration of tissues [1]. However,
the interactions between these factors are not fully understood. It seems that designing an appropriate
niche—one that is optimally suited for promoting cellular regeneration—is the most difficult challenge
faced by researchers who aim to enhance the regeneration of muscle tissue [2]. The creation of a new
tissue, however, involves interactions between three basic elements: cells capable of proliferation,
differentiation, and creating interconnections; scaffolds that act as mechanical foundations for growth;
Int. J. Mol. Sci. 2020, 21, 4173; doi:10.3390/ijms21114173 www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2020, 21, 4173 2 of 16
and growth and functional factors [3]. Many studies have been devoted to the invention and adaptation
of synthetic or biological niche environments for tissue engineering.
Carbon is relatively biocompatible and is a promising scaffold material. Carbon nanomaterials
can be used to create scaffolds of various structural types and can impart features of regularity and,
most importantly, flexibility. This allows for the imitation of the physiological structures characteristic
of the muscle niche. Graphene, particularly, graphene oxide (GO), easily attaches to other compounds
through interactions involving the surface oxygen groups and can create a surface containing a mosaic
of chemical groups that are exposed to the environment [4]. It has a great physical and chemical
plasticity and possesses a strong and durable graphene mesh structure [5,6], which possesses favorable
characteristics and facilitates formation of a scaffold with the potential action as a graphene-derived
synthetic extracellular matrix (ECM) structure [7]. The presence of numerous oxygen groups on the
GO surface enhances its hydrophilicity and biocompatibility [8], improving its biological applicability.
Key elements of tissue formation involve interactions between the ECM and the cells that
are capable of proliferation, differentiation, and creation of interconnections. However, many key
phenomena involved in these interactions have not been sufficiently elucidated. In particular,
the physicochemical impact of components of the ECM on myogenic progenitor cell proliferation,
differentiation, tissue formation, and, above all, activation of extracellular signaling are not clear.
The embryonic chicken muscle development model can provide a precise, convenient and rapid means
to study interactions between the myogenic progenitor cells and the potential ECM mimics. Muscle
tissues of chicken embryos are formed similarly to those of other animals. Multipotent stem cells of the
mesoderm ignite somites and leg buds arise from somites 26 to 32 throughout 17 Hamburger–Hamilton
stages (HH) (52–64 h) and up to 26 HH (day 5) [9]. Stimulated myoblast precursors migrate to the
limb bud and are guided and nourished by the substances of the extracellular matrix present in the
peripheral mesenchyme of the limb bud.
Proliferating precursors of muscle cells have express specific proteins throughout specific stages
of tissue development, which extends from proliferation to differentiation. In order from the earliest to
the latest, the proteins expressed include MYF5 (myogenic factor 5), MyoD (myogenic differentiation
1), MRF4 (myogenic factor 6), and myogenin. MyoD controls the chromatin context and manages
the genes involved in myogenic programming [10]. MyoD is a marker of skeletal muscle cells and,
together with Myf5, is essential for the establishment of a viable muscle lineage [11].
Muscle cells and their precursors, however, exhibit not only endocrine, but also paracrine
properties. In vitro studies of muscle satellite cells co-cultured with endothelial cells have found
them to greatly stimulate angiogenesis [12]. Moreover, VEGF secretion by muscle satellite cells was
observed, indicating that muscle satellite cells secrete proangiogenic factors into the environment
and create a niche for their development and the formation of muscle tissue. Another study showed
that the coupling between the ECM and myogenic precursor cells (MPCs) activated myogenesis and
angiogenesis [13]. Cooperation between muscle and endothelial cell regeneration at the molecular
level (production of apelin, periostin, and oncostatin) conditioned the regeneration of muscle.
The purpose of the present study was to examine whether GO scaffolds are able to stimulate the
myogenic progenitor cell differentiation, which includes the stimulation of endocrine properties and
enhances their active participation in the construction of muscle tissue. The research is focused on the
scaffold interaction with the cells and its role in the promotion of tissue formation.
2. Results
2.1. GO Scaffold Characterisation
GO (50 mg/L) formed a stable aqueous hydrocolloid (zeta potential: −27.0 mV) that showed GO
flakes with an average diameter from 5 to 30µm via transmission electron microscopy (TEM) (Figure 1C).
The GO scaffold was analyzed using scanning electron microscopy (SEM) and atomic force microscopy
(AFM). A 1 mg/mL aqueous GO hydrocolloid was used to prepare the GO scaffold. SEM images
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showed layers of GO flakes covering the surface of cell culture plates (Figure 1F). AFM analysis was
performed to assess the GO scaffold on a cell culture plate and a perfectly flat silicon wafer. AFM
analysis of the GO scaffold on the silicon wafer showed that GO formed a surface with sharp peaks and
the average roughness of 5.1 nm (Figure 1D,E). The GO scaffold created using a polystyrene cell culture
surface had an increased number of peaks but a reduced average roughness of 2.0 nm (Figure 1A,B),
which indicated that GO fills cavities of polystyrene cell cultures, which leaves surfaces less rough.
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Figure  1. Graphene  oxide  scaffold morphology.  (A) Atomic  force microscopy  images  and  (B)  a 
topography model of the surface of the graphene oxide scaffold on a polystyrene culture plate. (C) 
Transmission electron microscopy image of graphene oxide. (D) Atomic force microscopy images and 
(E) a topography model of the graphene oxide scaffold surface on a flat silicon wafer. (F) Scanning 
electron microscopy image of the graphene oxide scaffold. 
2.2. PMC Localise Preferentially on GO Scaffold 
Organs/tissues dissected from a different part of the body (a hind limb (PMC), heart (PHC), brain 
(PNC), an eye (PEC), and a blood vessel from the chorioallantoic membrane (PVC)) were sources of 
mesenchymal cells involved in development of specific organs or tissues. GO enhanced viability of 
PMC and PEC, but decreased viability of PVC and did not affect PNC and PHC viability (Figure 2). 
To  clearly  observe morphological  differences  between  the  cells  grown  on  the GO  scaffold  and 
polystyrene, as well as to assess the direction of movement and homing preference of the GO surface, 
an island pattern was used (Figure 2K). Thus, we compared morphologies of cells on the GO island 
with those growing beyond GO and on the border of the GO island. A morphological assessment of 
cells  revealed  that  cells  were  typical  for  the  period  of  embryonic  development  assessed. 
Mesenchymal stem cells and differentiated cells were observed in each sample. All cells were located 
on  the polystyrene surface, on  the border of  the GO  island, and on  the GO  island, however,  they 
varied with respect to density and morphology (Figure 2). PMC, unlike other observed cells, actively 
localized on GO islands. (Figure 2B), whereas non‐PMC were located outside the GO. Images of the 
GO  island border showed  that cells predominantly  localized parallel  to  the GO border, however, 
sometimes they attached to the GO scaffold (Figure 2D,F,H,J). The GO scaffold was not definitively 
avoided  by  PHC,  PNC,  PEC,  and  PVC,  however,  any  preference  to  locate  on  the GO was  not 
observed. 
Figure 1. ra e e xi e scaff l r ology. ( ) to ic force microscopy images and (B) a
topography odel f t surface of the graph ne oxide scaffold on a polystyrene cultur plate.
(C) Transmission electron micr scopy image of graphene oxide. (D) Atomic for e microscopy images
and (E) a t pography model of the graph ne oxide scaffold surface on a flat silicon wafer. (F) Sca ing
el ctron microscopy image of the graphe e i ff .
2.2. PMC Localise Preferentially on GO Scaffold
Organs/tissues dissected from a different part of the body (a hind limb (PMC), heart (PHC),
brain (PNC), an eye (PEC), and a blood vessel from the chorioallantoic membrane (PVC)) were
sources of esenchymal cells involved in development of specific organs or tissues. GO enhanced
viability of PMC and PEC, but decreased viability of PVC and did not affect PNC and PHC viability
(Figure 2). To clearly observe morphological differences between the cells grown on the GO scaffold
and pol styrene, as well as to ass ss the direction of movement and homing preference of the GO
surface, an island p ttern was used (Figure 2K). Thus, we com ared morphologies of cells on the
GO island with those gr wing beyond GO an on the border of the GO island. A morphological
asses m nt of cells revea ed that cells were typical for the period of embryonic d velopment as essed.
Mesenchymal stem cel s and differentiated c ll c sa ple. All cells were located
on the polystyrene surface, on the border of the GO island, and on the GO island, however, th y varied
with respect to density and morphology (Figure 2). PMC, unlike other observed cells, actively localized
on GO islands. (Figure 2B), whereas non-PMC were located outsid the GO. Images of the GO island
border showed that cells predominantly localized parallel to the GO border, however, sometimes they
attached to the GO scaffold (Figure 2D,F,H,J). The GO scaffold was not definitively avoided by PHC,
PNC, PEC, and PVC, however, any preference to locate on the GO was not observed.
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(unpaired t‐test; p < 0.05). (K) Pattern of GO islands used in cell localization and morphology analysis. 
Acronyms: C, control; GO, graphene oxide; RV, relative value. 
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Figure 2. l sis of the cell localization and viability on the GO scaffold. (A) Viability and
(B) morph logies of progenitor mus le cells from hind limb (PMC) on the GO scaffold. (C) Viability
and (D) morphology of progenitor ye cells (PEC) on the GO scaffold. (E) Viability and (F) morphology
of progenitor heart-derived cells (PHC) on the ff ilit and ( ) morphology of cells
derived from brain (progenitor nerve cells, PNC) on the GO scaffold. (I) Viabil ty and (J) morphology of
cells from a chorioallantoic membrane’s blood vessel (progenit r vessel c lls, PVC) on the GO scaffold.
Morphology was assessed on the edge of the GO scaffold via light microscopy with phase contrast and
200 × magnification. St tistical significance is indicated with different superscripts (unpaired t-te t;
p < 0.05). (K) Pattern of GO isl nds used in cell localization and morphology analysis. Acronyms:
C, control; GO graphene oxide; RV, relativ value.
To verify PMC behavior on the GO scaffold, as carried out after the cells
wer incubated with the GO scaffold for exten e ated for 96 h and imaged via
SEM showed a tendency to localize on isl f islands, ce ls were placed
perpendicularly to circle with protrusions dir cted towards the GO surface (Figure 3A).
SEM imaging allow d resea chers to distinguish b tween two layers of PMC. The first one was large
and contained flattened cells located at the bottom of wells. Th se cells a hered to the GO scaffold.
The second layer of cells grew over the bottom cell layer and consisted of oval, slightly rectangular
single and fused myoblasts (Figure 3B, ). Cells of the second layer, myogenic progenitor cells and
differentiated myocytes, had cytoplasmic protrusions that were connected to cells of the first layer.
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Figure 3. PMC morphology after a 96‐h incubation and PMC migration on a GO scaffold. (A) Scanning 
electron microscope visualization of PMC on the edge and (B,C) the center of the GO scaffold. (D) 
Visualization  of  the  whole  GO  scaffold  overgrown  by  PMC.  (E)  Representative  images  of  the 
migration analysis of PMC throughout the GO scaffold. Image of the  initial (“0 h”) position of the 
PMC and their positions after an 18‐h incubation period on a polystyrene culture plate (“C”) and a 
graphene oxide scaffold (“GO”). (F) Fold decreases of the cell‐free areas measured as the difference 
determined between 0 h and 18 h  images. Arrows  indicate  the edge of  the GO scaffold. Statistical 
significance  is  indicated with  different  superscripts  (unpaired  t‐test;  p  <  0.05). Abbreviations: C, 
control; GO, graphene oxide; RV, relative value. 
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cell reached the edge of the scaffold and began to migrate to the GO scaffold. Cells  in the control 
group (Figure 3E, “C”) covered the polystyrene surface during the 18‐h time‐lapse imaging period 
almost two times slower than the cells that migrated next to the GO scaffold (Figure 3E, “GO”).   
2.4. The GO Scaffold Increases Expression of the MyoD1 mRNA and Enhances Synthesis of VEGF‐A 
Proteins 
To explain mechanism of the PMC–GO scaffold interaction, mRNA expression levels of the key 
genes responsible  for myogenic progenitor cell differentiation, proliferation, and maturation were 
assessed. The GO scaffold influenced expression of the genes involved in myogenic progenitor cell 
proliferation and differentiation. The GO surface enhanced expression of MyoD1, which is the gene 
responsible  for differentiation,  and decreased  expression of  the proliferating  cell nuclear  antigen 
(PCNA) involved in proliferation and of ATP5B (coding ATP synthase F1 subunit beta). However, 
the  GO  scaffold  did  not  affect  basic  fibroblast  growth  factor  (bFGF  expression  (Figure  4). 
Interestingly, VEGF‐A gene indicating the angiogenesis process was upregulated after application of 
Figure 3. P C orphology after a 96-h incubation and P C igration on a scaffold. ( ) Scanning
electron icroscope visualization of PMC on the edge and (B,C) the center of the GO scaffold.
(D) Visualization of the whole GO scaffold overgrown by PMC. (E) Representative i ages of the
igration analysis of P C throughout the GO scaffold. I age of the initial (“0 h”) position of the
P C and their positions after an 18-h incubation period on a polystyrene culture plate (“C”) and a
graphene oxide scaffold (“GO”). (F) Fold decreases of the cell-free areas measured as the difference
determined between 0 h and 18 h images. Arrows indicate the edge of the GO scaffold. Statistical
significance is indicated with different superscripts (unpaired t-test; p < 0.05). Abbreviations: C, control;
GO, graphene oxide; RV, relative value.
2.3. The GO Scaffold Increases Migration of PMC
To assess PMC surface preference, cell migration speed on the control polystyrene and the
polystyrene covered with a GO scaffold were analyzed. Analysis of migration was initiated when the
cell reached the edge of the scaffold and began to migrate to the GO scaffold. Cells in the control group
(Figure 3E, “C”) covered the polystyrene surface during the 18-h time-lapse imaging period almost
two times slower than the cells that migrated next to the GO scaffold (Figure 3E, “GO”).
2.4. The GO Scaffold Increases Expression of the MyoD1 mRNA and Enhances Synthesis of VEGF-A Proteins
To explain mechanism of the PMC–GO scaffold interaction, mRNA expression levels of the key
genes responsible for myogenic progenitor cell differentiation, proliferation, and maturation were
assessed. The GO scaffold influenced expression of the genes involved in myogenic progenitor cell
proliferation and differentiation. The GO surface enhanced expression of MyoD1, which is the gene
responsible for differentiation, and decreased expression of the proliferating cell nuclear antigen
(PCNA) involved in proliferation and of ATP5B (coding ATP synthase F1 subunit beta). However,
the GO scaffold did not affect basic fibroblast growth factor (bFGF expression (Figure 4). Interestingly,
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VEGF-A gene indicating the angiogenesis process was upregulated after application of the GO scaffold.
To analyze cell secretion of VEGF-A, the level of this protein in media was assessed. The concentration
of VEGF-A in the culture medium from the PMC incubated on the GO surface was increased as
compared to the control (Figure 4).
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Figure 4. Analysis of mRNA expression and protein level. (A) Vascular endothelial growth factor A 
(VEGF‐A) protein level in the cell medium after incubation of PMC on a standard cell culture plate 
(control—“C”), PMC on the graphene oxide scaffold (“GO scaff”), PMC on a standard cell culture 
plate  treated with GO  (final  concentration—10  μg/mL). Expression  level  of  the  genes  coding  (B) 
VEGF‐A, (C) basic fibroblast growth factor (bFGF), (D) myoblast determination protein 1 MyoD, (E) 
ATP  synthase  F1  subunit  beta  ATP5B,  (F)  proliferating  cell  nuclear  antigen  PCNA.  Statistical 
significance is indicated with different superscripts (one‐way ANOVA; p < 0.05). Abbreviations: RU, 
relative units. 
To confirm the release of VEGF‐A, PMC cultured on a GO surface ex ovo and tube formation 
angiogenesis models were assessed. To evaluate proangiogenic properties of the PMC culture media, 
a GO scaffold human umbilical vein endothelial cells (HUVEC) tube formation assay was performed. 
The medium from the PMC cultured on a GO scaffold was used as an experimental group (Figure 
5C), the medium from the PMC cultured on a standard polystyrene surface was used as a control 
(Figure 5B). Additionally, freshly supplemented DMEM was used as a negative control (Figure 5A). 
The number of tube junctions formed after incubation with experimental and control media indicated 
angiogenic potential. The number of junctions formed after exposure to the experimental group was 
statistically higher than that of the control and negative control groups (Figure 5D). 
Additionally, proangiogenic properties of  the medium were verified using an  implant  taken 
from the peripheral blood vessel of a chicken embryo. After a 3‐d  incubation period, the vascular 
implants subjected to culture media from the control PMC and the PMC cultivated on a GO scaffold 
significantly differed. The fragment of the vessel that was cultured in the presence of the control PMC 
media was weakly altered. Groups of single cells in the vicinity of dense vessel tissue were clearly 
visible (Figure 5E,F). Morphological features of these cells corresponded to those of endothelial cells. 
Figure 4. Analysis of mRNA expression and protein level. (A) Vascular endothelial growth factor A
(VEGF-A) protein level in the cell medium after incubation of PMC on a standard cell culture plate
(control—“C”), PMC on the graphene oxide scaffold (“GO scaff”), PMC on a standard cell culture plate
treated with GO (final concentration—10 µg/mL). Expression level of the genes coding (B) VEGF-A,
(C) basic fibroblast growth factor (bFGF), (D) myoblast determination protein 1 MyoD, (E) ATP synthase
F1 subunit beta ATP5B, (F) proliferating cell nuclear antigen PCNA. Statistical significance is indicated
with different superscripts (one-way ANOVA; p < 0.05). Abbreviations: RU, relative units.
To confirm the release of VEGF-A, PMC cultured on a GO surface ex ovo and tube formation
angiogenesis models were assessed. To evaluate proangiogenic properties of the PMC culture media,
a GO scaffold human umbilical vein endothelial cells (HUVEC) tube formation assay was performed.
The medium from the PMC cultured on a GO scaffold was used as an experimental group (Figure 5C),
the medium from the PMC cultured on a standard polystyrene surface was used as a control (Figure 5B).
Additionally, freshly supplemented DMEM was used as a negative control (Figure 5A). The number
of tube junctions formed after incubation with experimental and control media indicated angiogenic
potential. The number of junctions formed after exposure to the experimental group was statistically
higher than that of the control and negative control groups (Figure 5D).
Additionally, proangiogenic properties of the medium were verified using an implant taken from
the peripheral blood vessel of a chicken embryo. After a 3-d incubation period, the vascular implants
subjected to culture media from the control PMC and the PMC cultivated on a GO scaffold significantly
differed. The fragment of the vessel that was cultured in the presence of the control PMC media
was weakly altered. Groups of single cells in the vicinity of dense vessel tissue were clearly visible
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(Figure 5E,F). Morphological features of these cells corresponded to those of endothelial cells. A blood
vessel scrap grown in the presence of the medium from the PMC cultured on a GO scaffold was more
drastically altered. Its edges were more jagged, and cells migrated away from the sample.
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Figure 5. Analysis of angiogenic properties of PMC media. Images of human umbilical vein endothelial
cells (HUVEC) tube formation in (A) the control medium and (B) the negative control medium with
the post-incubation addition of the medium from the PMC cultured under standard conditions as
the control, and (C) with the post-incubation addition of the medium from the PMC cultured on a
graphene oxide scaffold. (D) Graph showing the mean number of junctions of HUVEC tubes in the
field of view. Values are expressed as mean ± standard deviation. Statistical significance is indicated
with different superscripts (one-way ANOVA; p < 0.05). (E) Implant from the peripheral blood vessel of
a chicken embryo incubated in the medium derived from standard PMC cultures (negative control) and
(F) analysis of cells incubated in the medium from the PMC cultured on graphene oxide. Abbreviations:
RV, relative value; N, negative control; C, control; GO scaff, experimental group.
3. Discussion
GO is a extremely thin, resilient, light, and durable structure. It is considered a basement,
or ECM-equivalent, structure. According to Kenry et al. [14], superior properties of graphene and
graphene-like materials may enhance the regeneration capacity of tissues in a controlled way. However,
application of GO as a substructure for cellular proliferation and differentiation requires examination
of its toxicity. The problem of potential GO toxicity has inspired an increasing number of in vitro
and in vivo studies. Several studies showed that intratracheal exposure to GO is highly toxic [15].
Sydlik et al. [16] stated that the GO implanted subcutaneously and intraperitoneally was moderately
compatible with the inflammatory response. In the previous work, we showed that the short- and
long-term exposure of rats to intraperitoneal GO did not produce toxicity [17,18]. It seems that
toxicity of GO remains controversial and depends on many factors, including the graphene source,
the biological medium used, and the experimental protocol. When introduced to the culture medium,
GO was internalized and localized to F-actin filaments, which altered cell–cycle progression, apoptosis,
and oxidative stress [19]. In our experiments, however, GO was immobilized as a scaffold and did
not int ract with the acti inside the cell. In vitro experim nts carried out using st ndard methods
introduced experimental anomaterials to the culture medium, but insufficiently evaluated affi ity.
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For this reason, an “affinity test” was performed. All cells were seeded on 6-well plates using an island
pattern, which was prepared using the GO hydrocolloid. This allowed researchers to observe behavior
of the cells that were free to undergo both migration and colonization of GO islands or plate areas
between islands. This “nano-island” strategy was used to assess protein-detecting sensors [20] by
Lunova et al. [21], who assessed properties of liver cancer cells. In our experiments, we used a similar
island method to assess cell affinity and propensity for colonization.
Another group of studies have determined that different levels of toxicity for GO depend on the
chemical groups available on the surface of the material, and primarily on the amount of oxygen,
especially of the C = O groups, available, which is inversely proportional to toxicity [22,23]. In this
study, GO with a moderately high oxygen content (39–49%) was evaluated. Differences in GO
biocompatibility also depend on biological models and the type of cells used. We have shown that
expected differences in biocompatibility of GO can be observed using cells taken from different areas
of the embryo. GO was investigated as a nanoscaffold prepared by applying and drying GO flakes that
had been suspended in water at the bottom of a culture plate. Self-assembly of GO flakes produced a
very thin layer that adhered to the GO scaffold at the bottom of the dish. The cells dissected from the
peripheral blood vessels (PVC) reacted negatively to the GO scaffold. In contrast, the cells dissected
from muscle (PMC) and eye (PEC) tissue had increased numbers when exposed to GO and GO did
not affect growth of heart (PHC)- and brain (PNC)-derived cells. Thus, it can be assumed that in
regenerative medicine, consideration must be paid to using compatible cells and surfaces.
Here, we evaluate the potential of GO to act as the ECM. The nanoscaffold’s ECM-like surface
should be non-toxic and provide an adequate surface for cell adherence. Interestingly, all types of cells
were observed attached to the GO scaffold. Regardless of the cell type, graphene islands were never
completely avoided by cells. This indicated that GO was moderately biocompatible and confirmed the
previous experiments that used GO as a nanoscaffold component. Introducing GO to polycaprolactone
nanofiber scaffolds increased differentiation of mouse marrow mesenchymal stem cells (mMSC) to
osteo-like cells and rat pheochromocytoma cells (PC12-L) to neuro-like cells [24]. Moreover, a chicken
embryo muscle extract together with GO were used for the maturation of muscle progenitor cells [25].
Biocompatible GO was also used to reinforce gelatin–hydrphyapatitie 3D scaffolds and promoted
bone regeneration in orthopedics [26]. Moreover, GO was used to reinforce electrospun gelatin or PCL
scaffolds, increased tensile strength, and provided energy at the site of a break [27]. In other studies,
GO–PCL and GO sheets were shown to be biocompatible. Further, they both facilitated myoblast
differentiation from human mesenchymal stem cells [28]. The authors suggested that GO sheets and
GO-based scaffolds were the most favorable hydrocolloids assessed for promoting skeletal muscle
and other tissue regeneration. Additionally, other authors indicated that the reduced graphene oxide
nanoribbon grid facilitated rapid osteogenic differentiation [29].
In light of the results of our experiments assessing different types of mesenchymal cells, GO was
most suitable for regenerating muscle cells. Effects of extended incubation on migration revealed
a strong affinity of PMC for the GO scaffold. This may be a result of mechanical or/and chemical
properties of the GO scaffold surface. Mechanical properties, particularly with respect to elastic
modulus, of mammalian cells (between 1 to 100 kPa [30]) vary. Mechanotransduction-sensitive signaling
regulates myogenic differentiation, as well as endocrine and exocrine activities of these cells. It has been
demonstrated that elasticity (12 kPa) of the matrix of myogenic progenitor cells influences their capacity
to self-renew and restore muscle tissue [31]. In other studies, polyurethane–nano-GO nanofibrous
scaffold was used for stimulation of myogenic differentiation due to nanofibrous morphology and
high mechanical flexibility [32].
The challenge of creating nanosurface involving cellular interactions was discussed by
Liu and Tang [33], who argued that ECM-like nanoparticle structures influence cellular movement
and attachment, which can be visualized via assessment of lamellipodia or/and filopodia occurrence.
In our experiment, the filopodia of all cells were observed at the borders of scaffold islands, mainly
in the cells located parallel to GO islands, and filopodia were directed towards the scaffold. PMC,
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however, had lamellipodia that were positioned outstretched on the GO scaffold surface perpendicular
to the GO surface. Visualization of PMC with SEM revealed the tendency of cells to migrate, attach to
GO scaffolds, and revealed their preference to settle on GO islands. Moreover, the specific organization
of cells throughout growth was observed. Tissues collected from embryonic hind buds consisted
of undifferentiated cells, which differentiated and fused to form multinucleated myofibers. During
embryogenesis, primary myotubes are established on day 4–7 to form the scaffold and to differentiate
to form secondary myotubes on day 8–16 [34]. In our experiments, visualization via SEM revealed
scaffolding layers that were created by primary muscle cells. Further, differentiating elongate and
thin cells were connected to scaffolding cells. However, muscle fibers only formed when cells were
connected to undifferentiated scaffolding cells to form a feeding-like layer or if they were connected
to GO. Moreover, GO strongly promoted the signaling required for differentiation. An assessment
of MyoD gene expression in the PMC incubated on either GO scaffolds or in the presence of the
GO hydrocolloids revealed increased MyoD expression. MyoD is an early determinant of myogenic
progenitor cells to the myogenic lineage. In particular, MyoD stimulates myoblasts to promote
differentiation [35]. This regulator of myogenesis is expressed in proliferating myoblasts [36] and is
capable of transdifferentiating many different kinds of cells to muscle cells [10,37]. Our results revealing
increased expression of MyoD in the cells confirm the hypothesis that GO has pro-differentiation,
rather than pro-proliferative, effects. Moreover, myoblast differentiation is correlated with decreased
expression of a regulator of proliferation, PCNA, a phenomenon that was also observed in this study.
However, expression of MyoD genes is often negatively correlated with bFGF expression [38]. In our
study, exposure to a scaffold was not accompanied with the decreased expression of FGF2.
Studies of scaffolds also emphasized the role of the environment in shaping the regeneration of
muscle tissue, especially hypoxia [31,39]. During ageing and muscle degeneration, satellite cells lose
their ability to communicate and interact with the cells involved in angiogenesis [40]. The formation of
blood vessels is fundamental for formatting new tissue, because they facilitate the delivery of oxygen,
nutrients, and functional factors to cells. Therefore, the induction of angiogenesis by scaffolds enhances
tissue regeneration. Acellular collagen–heparin scaffolds showed induced angiogenesis by secretion of
VEGF and FGF2, ensuring lack of hypoxic cells [41]. In different studies, release of VEGF and IGF-1
from macroporous scaffolds enhanced muscle regeneration [42]. In our investigation, angiogenesis was
induced due to upregulation of VEGF-A transcription and protein synthesis after PMC were cultured
on a GO scaffold. In experiments using a mouse multipotent mesenchymal progenitor muscle cell
line, C2C12, Bryan et al. [43] showed that VEGF expression is coordinately controlled with myogenic
differentiation. Moreover, the study showed that MyoD is necessary for maintenance of proper levels
of VEGF expression and endogenous synthesis of MyoD promotes VEGF expression. These findings
are in accordance with our results, which showed that increased expression of MyoD is accompanied
by increased VEGF levels, however, we also showed that increasing VEGF expression at transcript
and protein levels compared with controls occurred in the cells cultured with GO scaffolds. In other
experiments, activation of VEGF expression in mesenchymal stromal cells after vibration stimulation
was observed [27]. Moreover, multi-layered electrospun scaffolds with macroporosity were used to
facilitate angiogenesis in a tissue-engineered smooth muscle. The 25% macroporous group showed
increased angiogenesis and improved implanted cell survival [44]. Mechanical impact on the cell
likely triggers mechanisms determining cell fate. The GO scaffold induced VEGF release by myogenic
cells, which indicated that surface and cell interactions play a key role in differentiation. Myogenic
progenitor cells used in our experiments exhibited a preference for the GO scaffold and subsequently
initiated differentiation.
This study revealed that the GO scaffold was readily populated and colonized by PMC and
simultaneously activated exocrine VEGF secretion. Our findings show that GO scaffolds can initiate
processes of muscle cell differentiation and stimulate angiogenesis due to mechanical interaction
with PMC.
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4. Materials and Methods
4.1. Graphene Oxide Scaffold
A GO water suspension (4 mg/mL) was purchased from Nanopoz, Poznan´. GO flakes were
produced from graphite using a modified Hummers method. Experimental scaffolds comprised of GO
were prepared as previously described [45]. In short, the GO hydrocolloid (1 mg/mL) was applied to
the bottom of a 6-well plate and dried in a laminar chamber. GO was applied such that it covered
either 100% or 20% of its surface by placing GO hydrocolloid drops to the surface to form islands that
spread throughout each well. To assess cytotoxicity of GOs, 20 µL of GO hydrocolloids were placed at
the bottom of each well of a 96-well microplate and dried for 2 h.
Morphologic features of GO were assessed via TEM imaging using a JEM-1220 microscope
(JEOL, Tokyo, Japan) equipped with a Morada 11 megapixel camera (Olympus Soft Imaging Solutions,
Münster, Germany) at 80 kV. Samples were prepared by placing a GO droplet onto formvar-coated
copper grids (Agar Scientific Ltd., Stansted, UK). Samples were air-dried before they were examined.
Zeta potential measurements were carried out using a Nano-ZS90 Zetasizer (Malvern Instruments,
Malvern, UK) instrument at 25 ◦C using the Smoluchowski approximation. Each sample was measured
after 120 s of stabilisation at 25 ◦C.
The surface of GO was analyzed via AFM and SEM. AFM imaging was performed using MFP
3D BioAFM with a commercial triangular cantilever (MPLCT, Bruker, Camarillo, CA, USA), spring
constant k = 0.10 N/m in dynamic (AC) mode. SEM imaging was performed using a Quanta 200
microscope (FEI, Hillsboro, OR, USA). Each GO scaffold was pre-dried on the bottom of a 6-well plate
in a laminar flow cabinet. Subsequently, each scaffold was contrasted with 1% osmium tetroxide
(Sigma-Aldrich, Munich, Germany) and 1% carbohydrazide (Sigma-Aldrich) and dehydrated in
increasing concentrations of hexylene glycol (Sigma-Aldrich). Drying was performed using a Polaron
CPD 7501 critical point dryer (Quorum Technologies, Laughton, UK).
4.2. Cell Culture
Mesenchymal cells were taken from 6-d-old chicken embryos. Fertilized chicken (Ross 308)
eggs were purchased from a hatchery and maintained in an incubator under standard conditions.
After incubating for 6 days, eggs were removed, and embryos were put on Petri dishes. Using a
stereoscopic microscope, different parts of the body, including the hind limb, heart, brain, eye, and blood
vessels from the chorioallantoic membrane were dissected and placed into tubes containing trypsin for
24 h at 5–8 ◦C. Next, trypsin and collected organs were neutralized with DMEM and tissue samples
were disintegrated by passing through tips and placed in 75 mL flasks. Cells were maintained in
DMEM (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum
(FBS, Thermo Fisher Scientific) and 1% penicillin/streptomycin (Thermo Fisher Scientific) at 37 ◦C
in a humidified atmosphere of 5% CO2 and 95% air in an incubator (NuAire DH AutoFlow CO2
Air-Jacketed Incubator, Plymouth, MA, USA). After one day, fresh DMEM was supplied and cells were
cultured until a confluence of 80% was reached. Cells were detached using trypsin and placed on
experimental 6-well plates (1 × 105 cells per well) and cultured.
HUVEC were obtained from Thermo Fisher Scientific and maintained in the M200PRF basal
media supplemented with a large vessel endothelial supplement (Thermo Fisher Scientific) and 1%
penicillin/streptomycin (Thermo Fisher Scientific). Cells were maintained at 37 ◦C in a humidified
atmosphere of 5% CO2 and 95% air.
4.3. Cell Morphology
Primary mesenchymal cells originating from a hind limb (PMC), primary heart cells (PHC),
primary neuronal cells originating from the brain (PNC), primary eye cells (PEC), and primary blood
vessel cells isolated from the chorioallantoic membrane (PVC) were assessed using an optical inverted
microscope (TL-LED, Leica Microsystems GmbH, Wetzlar, Germany) connected to a digital camera
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(Leica MC190 HD) using LAS V4.10 software. Cells were seeded (1 × 105 cells per well) in 35 mm
diameter Petri dishes with and without GO scaffolds. After incubation for 24 h, samples were imaged.
PMC were additionally visualized using a Quanta 200 SEM (FEI, Hillsboro, OR, USA). Cells
were seeded (1 × 105 cells per well) in 35 mm diameter Petri dishes with and without GO scaffolds.
After a 96-h incubation period, samples were prepared as described by Heckman et al. [46]. Cells were
fixed using 2.5% glutaraldehyde in phosphate-buffered saline (PBS) at pH 7.2, contrasted with 1%
osmium tetroxide (Sigma-Aldrich) and 1% carbohydrazide (Sigma-Aldrich). Subsequently, cells were
dehydrated in increasing concentrations of hexylene glycol (Sigma-Aldrich). Drying was performed
using a Polaron CPD 7501 critical point dryer (Quorum Technologies, Laughton, UK).
4.4. Cell Viability
The viability of PMC, PHC, PNC, PEC, and PVC grown on the GO scaffold was assessed using a
Presto blue assay (Thermo Fisher Scientific). PMC, PHC, PNC, PEC, and PVC were seeded in 96-well
microplates with and without GO scaffolds (1 × 104 cells per well in 100 µL of supplemented DMEM
media) and incubated for 24 h. Subsequently, 11 µL of the Presto blue reagent were added to each well
and results were examined using a Tecan Infinite 200 microplate reader (Tecan, Durham, NC, USA)
after a 3 h incubation step in accordance with the manufacturer’s instructions.
4.5. Analysis of PMC Migration on a GO Scaffold
To analyze PMC migration on a GO scaffold, cells and GO hydrocolloids were applied to separate
wells of a silicone insert (2-well culture inserts, Ibid, Gräfelfing, Germany) attached to a 35 mm
dish (µ-Dish 35 mm, high, Ibidi). Initially, 50 µL of GO hydrocolloids (10 µg/mL) were applied to
wells of the silicon insert and were allowed to dry using a laminar flow cabinet. Subsequently, PMC
(1 × 104 cells per well in a total volume of 70 µL) were seeded in a well without GO. After the cells
reached confluence, the silicon insert was gently removed and the cells were incubated for additional
48 h to allow them to migrate to the edge of the GO scaffold. After incubation, media were exchanged
for 3 mL DMEM supplemented with4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, final
concentration—20 mM). The cells were imaged using a confocal FV-1000 (Olympus Corporation,
Tokyo, Japan) microscope equipped with an incubation chamber that maintained temperature of 37 ◦C.
PMC migration on the GO scaffold was analyzed using time-lapse imaging for 18 h (8 min intervals).
The analysis of the cell-free area at the initial (0 h) and 18 h timepoint was performed using the MRI
Wound Healing Tool macro (http://dev.mri.cnrs.fr/projects/imagejmacros/wiki/Wound_Healing_Tool)
for ImageJ software [47]. Migration rate was calculated as the average relative difference between the
cell-free areas at 0 and 18 h timepoints using 3 independent experiments. Full time-lapse images of the
cells grown on control surfaces and the GO scaffold are available in supplementary information.
4.6. mRNA Expression RT-PCR
To determine transcript levels of VEGF-A, FGF2, MyoD1, and PCNA, PMC were cultured in
6-well plates with and without a GO scaffold. GO hydrocolloids were added to a final concentration of
10 µg/mL, and the cells lacking a scaffold were used as a control. Next, 1 × 104 cells per well (passage 3)
were seeded onto each well and incubated for 3 days. The cells were washed with PBS, centrifuged
and stored at −80 ◦C. Gene expression levels were measured using the quantitative polymerase chain
reaction method (qPCR). PMC were homogenized in the TRIzol Reagent (Thermo Fisher Scientific),
and total RNA was extracted according to the manufacturer’s instructions. RNA samples were
purified using the SV Total RNA Isolation System (Promega Corporation, Madison, WI, USA) and
quantified using a NanoDrop ND 1000 spectrophotometer (Thermo Fisher Scientific). Total RNA
(2 mg) was reverse transcribed using a reverse transcriptase with oligo (dT) (Promega) and random
primers (TAG Copenhagen A/S, Copenhagen, Denmark). Subsequently, real-time PCR was performed
using complementary DNA and gene-specific primer pairs (TAG, Copenhagen A/S, Copenhagen,
Denmark) mixed with the LightCycler 480 SYBR Green I Master mix (Roche Applied Science, Penzberg,
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Germany) in a LightCycler 480 real-time PCR system (Roche Applied Science, Penzberg, Germany).
The primers used are listed in Table 1. For each complementary DNA, reactions were performed
in triplicate. To determine transcript levels, relative quantification was conducted using the ACTB
housekeeping gene.
Table 1. Primers used for real-time PCR.
Target Forward Primer Reverse Primer
FGF2 GGCACTGAAATGTGCAACAG TCCAGGTCCAGTTTTTGGTC
VEGF-A TGAGGGCCTAGAATGTGTCC TCTTTTGACCCTTCCCCTTT
PCNA TGCACGCATTTGTAGAGACC AGTCAGCTGGACTGGCTCAT
MyoD1 CGGCGGCTCAGCAAGGTCAAC CGGCCCGCTGTACTCCATCATG
ATP5B GTTATTCGGTGTTCGCTGGT GTAGACCAGAGCGACCTTGG
ACTB GTCCACCTTCCAGCAGATGT ATAAAGCCATGCCAATCTCG
4.7. Quantification of VEGF-A Protein Secretion
PMC cells were seeded (1 × 105) and cultured in 75-mL flasks (covered with GO or not covered as
a control) in the supplemented DMEM media. The media were changed after 3 days. After 6 days,
all media were removed, and the cells were washed twice with warmed PBS without calcium and
magnesium ions (Thermo Fisher Scientific). Subsequently, the cells were starved in DMEM without
serum for 2 days, and culture media were centrifuged at 1,500 rpm at 4 ◦C for 10 min, aliquoted,
and stored at −80 ◦C for later use. Cell-free supernatants of cultures were used for the determination
of secreted VEGF-A levels using a chicken VEGF-A kit (Mybiosource, San Diego, CA, USA). The assay
was performed according to the manufacturer’s instructions and absorbance was measured using a
microplate reader (Tecan Infinite 200, Durham, NC, USA) at 450 nm.
4.8. Angiogenesis Potential of PMC
The angiogenic potential of PMCs was analyzed using a HUVEC tube formation assay. Tube
formation was performed using µ-Slide Angiogenesis (Ibidi, Gräfelfing, Germany) slides coated with
the 10 µL Geltrex Reduced Growth Factor Basement Membrane Matrix (Thermo Fisher Scientific).
Cells were suspended in media composed of supplemented M200PRF (80%) and a fresh supplemented
DMEM medium (20%) (negative control), supplemented M200PRF (80%) and a post-culture DMEM
(20%) obtained as described above for the PMC cultured without the GO scaffold (control group),
supplemented M200PRF (80%) and a post-culture DMEM (20%) from the PMC cultured on the GO
scaffold (experimental group). HUVEC suspensions (50µL) were seeded at a density of 1× 104 cells/well.
After 5 h of incubation, HUVEC tubes were fixed with 4% paraformaldehyde (Sigma-Aldrich) for
10 min. Subsequently, tubes were gently washed with PBS (Thermo Fisher Scientific) and stained with
the ActinRed 555 ReadyProbes Reagent (Thermo Fisher Scientific). Tubes were imaged using an FV1000
confocal microscope equipped with a 4 X objective (Olympus Corporation). The number of junctions
present within the tube mesh was assessed using the ImageJ software [47] and the Angiogenesis
Analyzer macro [48].
Proangiogenic properties of culture media used to grow PMC were also verified using an implant
taken from the peripheral blood vessel of a chicken embryo. On day 9 of the chicken embryo
development, 5 mm samples of a peripheral blood vessel were removed and placed in a 6-well plate
with the control medium (post-culture DMEM from the PMC cultured without a GO scaffold) and the
experimental medium (post-culture DMEM from the PMC cultured on a GO scaffold). After incubating
for 3 days, the vascular implant was fixed with 4% paraformaldehyde (Sigma-Aldrich) for 10 min,
stained with hematoxylin–eosin (Sigma-Aldrich), and imaged using an optical inverted microscope
(TL-LED, Leica Microsystems GmbH).
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4.9. Statistical Analysis
The data were analyzed using the one-way analysis of variance (for analysis of three or more
groups) or an unpaired t-test using GraphPad Prism 8 (GraphPad Software, San Diego, CA, USA).
The differences between the groups determined via the one-way analysis of variance were tested with
Tukey’s honest significant difference (HSD) post hoc test. The results are shown as means and standard
deviations. Differences of p < 0.05 were considered significant.
Supplementary Materials: Time-lapse images of the cells grown on control surfaces and the GO scaffold are
available in the supplementary information. Supplementary materials can be found at http://www.mdpi.com/
1422-0067/21/11/4173/s1.
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Abbreviations
ACTB actin beta
AFM atomic force microscope
ATP5B ATP synthase F1 subunit beta
DMEM Dulbecco’s Modified Eagle Medium
ECM extracellular matrix
FGF2 fibroblast growth factor 2
GO graphene oxide
HH Hamburger–Hamilton stage
HUVEC human umbilical vein endothelial cells
MyoD1 myogenic differentiation 1
PCNA proliferating cell nuclear antigen
PEC primary eye cells
PHC primary heart cells
PMC primary mesenchyme cells
PNC primary neuronal cells
PVC primary blood vessel cells
SEM scanning electron microscope
TEM transmission electron microscope
VEGF-A vascular endothelial growth factor A
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